Remarkably, lysosomal pathways synergistically increased mutant CALR and Tpo‐R degradation, and their induction decreased cell proliferation induced by mutant CALR in cell lines and proliferation of CD34 positive cells from MPN patients. This evidence concerns the gene CALR and myeloproliferative neoplasm.